Astellas surpassed market…
Astellas surpassed market expectations in its third-quarter fiscal year 2025 [...]
Angitia Biopharmaceuticals has…
Angitia Biopharmaceuticals has unveiled its second mega-round in 14 months, [...]
Clinical-stage antibody company…
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull [...]
Quell Therapeutics is pressing…
Quell Therapeutics is pressing pause on an engineered regulatory T-cell [...]
Bayer has linked asundexian to a…
Bayer has linked asundexian to a 26% reduction in stroke [...]
Eikon Therapeutics is heading to…
Eikon Therapeutics is heading to the Nasdaq this morning with [...]
F.T.C. Settles With Express Scripts Over High Insulin Prices
The Trump administration announced that the company, a pharmacy benefit [...]
Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
The once high-flying Danish drugmaker has struggled to fend off [...]
As Eli Lilly awaits an FDA…
As Eli Lilly awaits an FDA approval decision for its [...]
Novartis has nixed six early-stage…
Novartis has nixed six early-stage pipeline programs, swapping in two [...]